Illumina to acquire early cancer detection startup Grail for $8B - MedCity News
Illumina originally spun off Grail in early 2017. Grail plans to launch its test for early detection of cancers, Galleri, next year. Illumina already owns 14.5% of the company, which it started in 2016.| MedCity News
